M Gatti, F Pea - Clinical Pharmacokinetics, 2021 - Springer
Acute kidney injury represents a common complication in critically ill patients affected by septic shock and in many cases continuous renal replacement therapy (CRRT) may be …
Since the discovery of penicillin, β-lactam antibiotics have commonly been used to treat bacterial infections. Unfortunately, at the same time, pathogens can develop resistance to β …
DF Bavaro, A Belati, L Bussini, V Cento… - Expert Opinion on …, 2024 - Taylor & Francis
ABSTRACT Introduction Methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infection (BSI) is a major issue in healthcare, since it is often associated with endocarditis or …
Critically ill patients suffering from severe infections are prone to pathophysiological pharmacokinetic changes that are frequently associated with inadequate antibiotic serum …
A Alarcia-Lacalle, H Barrasa, J Maynar… - Pharmaceutics, 2021 - mdpi.com
This study was conducted to develop a rapid, simple and reproducible method for the quantification of ceftaroline in plasma samples by high-performance liquid chromatography …
Background: Currently, the escalation of microbial resistance poses a significant global challenge. Children are more susceptible to develop infections and therefore are prescribed …
A Alarcia-Lacalle, H Barrasa, J Maynar… - Blood …, 2023 - karger.com
Introduction: Continuous renal replacement therapies (CRRTs) are frequently used in critically ill patients; however, there are scarce in vitro and in vivo studies showing the …
M Garcia-Cremades, J Aparicio-Blanco… - … -Chemical Aspects of …, 2024 - Elsevier
Computational pharmacokinetic (PK) modeling and simulation are revolutionizing the fields of drug development and therapeutic use. PK models use mathematical equations to study …
S Di Bella - Authorea Preprints, 2023 - advance.sagepub.com
Microbiological, Clinical, and PK/PD Features of the New Anti-Gram-Negative Antibiotics: β-Lactam/β-Lactamase Inhibitors in Co Page 1 P osted on 14 Dec 2023 — The cop yrigh t holder is the author/funder …